KRSNAA DIAGNOSTICS Fact Sheet, KRSNAA DIAGNOSTICS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS Fact Sheet    (KRSN)


FREE REPLAY: Discover What Richa Revealed in Her Smallcaps Summit


Here is the latest financial fact sheet of KRSNAA DIAGNOSTICS. For more details, see the KRSNAA DIAGNOSTICS quarterly results and KRSNAA DIAGNOSTICS share price and chart. For a sector overview, read our pharmaceuticals sector report.

KRSNAA DIAGNOSTICS Price History

Price Rs 697.0
Mkt Cap Rs m 21,883
Vol '000 14.3
P/E X  
P/CF X 9.8
EPS (TTM) Rs 0.0
% ch % -0.1
No. of shares m 31.40
% ch week % 10.7
% ch 1-mth % 3.9
% ch 12-mth % -
52 week H/L Rs 1,099.5/624.5
(As on Nov 30, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

KRSNAA DIAGNOSTICS Financials

No. of Mths
Year Ending
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
KRSNAA DIAGNOSTICS EQUITY SHARE DATA
High RsNANANANA 
Low RsNANANANA 
Sales per share (Unadj.) Rs175.5284.7500.8998.8 
Earnings per share (Unadj.) Rs9.424.2-217.0284.5 
Diluted earnings per shareRs1.54.0-35.758.9 
Cash flow per share (Unadj.) Rs43.273.7-154.1342.1 
Dividends per share (Unadj.) Rs0000 
Adj. dividends per shareRs0.000.000.000.00 
Avg Dividend yield %NMNMNMNM 
Book value per share (Unadj.) Rs156.1366.3-381.7355.5 
Adj. book value per shareRs25.760.2-62.773.6 
Shares outstanding (eoy) m5.165.165.166.50 
Bonus / Rights / Conversions  ---- 
Price / Sales ratio x0000 
Avg P/E ratio x0000 
P/CF ratio (eoy) x0000 
Price / Book Value ratio x0000 
Dividend payout %0000 
Avg Mkt Cap Rs m0000 
No. of employees `000NANANANA 
Total wages/salary Rs m160182231296 
Avg. sales/employee Rs ThNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNM 
KRSNAA DIAGNOSTICS INCOME DATA
Net Sales Rs m9061,4692,5846,492 
Other income Rs m1423130122 
Total revenues Rs m9201,4922,7146,615 
Gross profit Rs m292598-1,1423,466 
Depreciation Rs m174256324374 
Interest Rs m77159247259 
Profit before tax Rs m54206-1,5832,955 
Minority Interest Rs m0000 
Prior Period Items Rs m0000 
Extraordinary Inc (Exp) Rs m0000 
Tax Rs m682-4641,105 
Profit after tax Rs m49125-1,1201,849 
Gross profit margin %32.240.7-44.253.4 
Effective tax rate %10.239.629.337.4 
Net profit margin %5.48.5-43.328.5 
KRSNAA DIAGNOSTICS BALANCE SHEET DATA
Current assets Rs m4871,9002,1362,481 
Current liabilities Rs m1,1571,7261,8081,838 
Net working cap to sales %-74.011.812.79.9 
Current ratio x0.41.11.21.4 
Inventory Days Days139955625 
Debtors Days Days115,406,075139,686,1298741 
Net fixed assets Rs m2,2213,0313,2423,564 
Share capital Rs m7011,4612022,489 
"Free" reserves Rs m104429-2,172-178 
Net worth Rs m8061,890-1,9702,310 
Long term debt Rs m5561,1191,2271,680 
Total assets Rs m2,7084,9315,3786,045 
Interest coverage x1.72.3-5.412.4 
Debt to equity ratio x0.70.6-0.60.7 
Sales to assets ratio x0.30.30.51.1 
Return on assets %4.65.7-16.234.9 
Return on equity %6.06.656.880.0 
Return on capital %9.612.1180.080.5 
Exports to sales %0000 
Imports to sales %0000 
Exports (fob) Rs m0000 
Imports (cif) Rs m0000 
Fx inflow Rs m0000 
Fx outflow Rs m0000 
Net fx Rs m0000 
KRSNAA DIAGNOSTICS CASH FLOW
From Operations Rs m 525 611 378 1,026 
From Investments Rs m -907 -2,014 -766 -611 
From Financial Activity Rs m 411 1,448 58 308 
Net Cashflow Rs m 29 45 -331 723 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 27.4%
Institution 36.2%
Non-Institution 36.5%
Total 100.0%
Free Float 72.6%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF S. No. 243 A-hissa No. 6, Cts No. 4519 4519/1 Near Chinchwad Station, Chinchwad Taluka Haveli, Pune - 411019
E-MAIL cs@krsnadiagnostics.com WEB www.krsnaadiagnostics.com
TEL 020-4695 4695 FAX
SECTOR HOSPITAL & HEALTHCARE SERVICES GROUP Private sector
TR AGENT K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
YEAR OF INC: 2010 BSE CODE: 543328 FV (Rs): 5 DIV YIELD (%): -

More Hospital & Healthcare Services Company Fact Sheets:   JENBURKT PH.  GSK PHARMA  BERYL DRUGS  MAKERS LAB.  GLENMARK PHARMA  

Compare KRSNAA DIAGNOSTICS With:   JENBURKT PH.  GSK PHARMA  BERYL DRUGS  MAKERS LAB.  GLENMARK PHARMA  




Today's Market

Sensex Falls 1,100 Points from Day's High to End Marginally Lower; Metal & Energy Stocks Witness Selling(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices reversed course in intraday deals as global cues turned bearish.

Views on news

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS - CHENNAI MEENAKSHI COMPARISON

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS